CC

Concord Medical Services Holdings Limited

CCMHealthcareNASDAQ

Medical Care Facilities

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$460.5M
+19.9% YoY
Net Income
-$92.8M
+69.9% YoY
EBITDA
-$71.8M
+79.2% YoY
Free Cash Flow
-$313.7M

Scan Results

Daily timeframe
2 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 15 MACD Negative CrossoverHistogram -0.0150, negative momentum
Jul 14 MACD Positive CrossoverHistogram +0.0127, positive momentum
About Concord Medical Services Holdings Limited

Part of the healthcare sector, Concord Medical Services Holdings Limited (CCM) is listed under Medical Care Facilities. With a market capitalization of $17.5M, it sits in micro-cap territory. It operates in two segments, Network and Hospital.

Where CCM stands vs its 150-day and 200-day moving averages

As of the July 15, 2026 close, CCM finished 2.34% above its 150-day moving average ($4.27) and 2.67% below its 200-day moving average ($4.49). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CCM overbought or oversold?

At the July 15, 2026 close, CCM's RSI(14) was 46.5, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$17.5M
Fwd P/E-26.87
EPS$-3.13
Beta-0.96
52W Change-28.8%
ROE-21.9%
Analysis

The company holds $297.8M in cash, though total debt stands at $3.63B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow is running at -$313.7M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -21.9% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has been relatively flat, moving from $472.1M (2022) to $460.5M (2025).

With a beta below 0.7, Concord Medical Services Holdings Limited typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Concord Medical Services Holdings Limited's trajectory.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms
CCM: Concord Medical Services Holdings Limited Technical Analysis (200-Day MA, RSI, MACD) | Scanance